Hospital admission rate in children and adolescents with mild persistent asthma

• Published in: Pediatric pulmonology Vol. 56; no. 7; pp. 1889 - 1895
• Main Authors: Ponte, Eduardo Vieira, Mingotti, Cintia Fernanda Bertagni, Mamoni, Ronei Luciano, Marchi, Evaldo, Martinelli, José Eduardo, Menezes, Marcelo Bezerra, Vianna, Elcio dos Santos Oliveira, Cruz, Álvaro Augusto
• Format: Journal Article
• Language: English
• Published: United States Wiley Subscription Services, Inc 01.07.2021
• Subjects: Asthma; corticosteroids; cost; epidemiology; exacerbation; Patient admissions; Teenagers; therapy; epidemiology; cost; corticosteroids; therapy; exacerbation
• ISSN: 8755-6863; 1099-0496; 1099-0496
• DOI: 10.1002/ppul.25363

Introduction The health and financial burden of mild‐persistent asthma has been poorly investigated. Objective Our aim was to compare the rate of hospital admissions that have occurred during the preceding year between children and adolescents with current mild‐persistent (MP) and moderate‐severe (MS) asthma. Methods We screened children and adolescents with asthma at eight outpatient clinics. The inclusion criteria were asthma diagnosis, age from 6 to 18 years and follow‐up with a physician during the preceding 6 months. Subjects answered standardized questionnaires and underwent spirometry. Results We enrolled 220 MP and 102 MS asthmatic subjects. The proportion of subjects with HA during the preceding year was similar between MP and MS asthma groups (7% vs. 7%; p = .89). Symptoms score and the financial values spent by the family in the care of asthma were lower in MP asthma as compared with MS asthma group (asthma control questionnaire score 0.7 [0.3–1.0) vs. 2.0 [1.1–2.5]; p < .01) (asthma expenses in USD 13 [2–43] vs. 28 [10–83]; p < .01). The frequency of subjects using inhaled corticosteroids maintenance therapy was lower in the MP asthma group as compared with the MS asthma group (54% vs. 100%; p < .01). Conclusion We conclude that the frequency of hospital admissions that have occurred during the preceding year was similar between subjects with current MP and MS asthma. Symptoms score and the financial values spent by the family in the care of asthma were lower in the MP asthma group.